Selected research
Industry Research
DPT Vaccines Industry Research Report 2026
Market perspective
The global DPT Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for DPT Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for DPT Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for DPT Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global DPT Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DPT Vaccines Market by Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
DPT Vaccines Segment by Type
DTaP
Tdap
DTwP
DPT Vaccines Segment by Age
12 Months Below
12 Months Above
DPT Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DPT Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DTaP
- Tdap
- DTwP
Applications
- 12 Months Below
- 12 Months Above
Companies covered
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global DPT Vaccines Market Size (2021-2032)
- 2.2.2 Global DPT Vaccines Sales (2021-2032)
- 2.2.3 Global DPT Vaccines Market Average Price (2021-2032)
- 2.3 DPT Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DTaP
- 2.3.3 Tdap
- 2.3.4 DTwP
- 2.4 DPT Vaccines by Age
- 2.4.1 Market Value Comparison by Age (2021 VS 2025 VS 2032)
- 2.4.2 12 Months Below
- 2.4.3 12 Months Above
3 Market Competitive Landscape by Manufacturers
- 3.1 Global DPT Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global DPT Vaccines Sales (M Doses) of Manufacturers (2021-2026)
- 3.3 Global DPT Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global DPT Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global DPT Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of DPT Vaccines, Product Type & Application
- 3.8 Global Manufacturers of DPT Vaccines, Established Date
- 3.9 Global DPT Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi Pasteur
- 4.1.1 Sanofi Pasteur Company Information
- 4.1.2 Sanofi Pasteur Business Overview
- 4.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
- 4.1.5 Sanofi Pasteur Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GSK DPT Vaccines Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 Mitsubishi Tanabe Pharma
- 4.3.1 Mitsubishi Tanabe Pharma Company Information
- 4.3.2 Mitsubishi Tanabe Pharma Business Overview
- 4.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
- 4.3.5 Mitsubishi Tanabe Pharma Recent Developments
- 4.4 KM Biologics
- 4.4.1 KM Biologics Company Information
- 4.4.2 KM Biologics Business Overview
- 4.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KM Biologics DPT Vaccines Product Portfolio
- 4.4.5 KM Biologics Recent Developments
- 4.5 Wuhan Institute of Biological Products
- 4.5.1 Wuhan Institute of Biological Products Company Information
- 4.5.2 Wuhan Institute of Biological Products Business Overview
- 4.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
- 4.5.5 Wuhan Institute of Biological Products Recent Developments
- 4.6 Walvax Biotechnology
- 4.6.1 Walvax Biotechnology Company Information
- 4.6.2 Walvax Biotechnology Business Overview
- 4.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
- 4.6.5 Walvax Biotechnology Recent Developments
- 4.7 Chengdu Institute of Biological Products
- 4.7.1 Chengdu Institute of Biological Products Company Information
- 4.7.2 Chengdu Institute of Biological Products Business Overview
- 4.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
- 4.7.5 Chengdu Institute of Biological Products Recent Developments
- 4.8 Minhai Biotechnology
- 4.8.1 Minhai Biotechnology Company Information
- 4.8.2 Minhai Biotechnology Business Overview
- 4.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
- 4.8.5 Minhai Biotechnology Recent Developments
5 Global DPT Vaccines Market Scenario by Region
- 5.1 Global DPT Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global DPT Vaccines Sales by Region: 2021-2032
- 5.2.1 Global DPT Vaccines Sales by Region: 2021-2026
- 5.2.2 Global DPT Vaccines Sales by Region: 2027-2032
- 5.3 Global DPT Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global DPT Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global DPT Vaccines Revenue by Region: 2027-2032
- 5.4 North America DPT Vaccines Market Facts & Figures by Country
- 5.4.1 North America DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America DPT Vaccines Sales by Country (2021-2032)
- 5.4.3 North America DPT Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe DPT Vaccines Market Facts & Figures by Country
- 5.5.1 Europe DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe DPT Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe DPT Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific DPT Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific DPT Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific DPT Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America DPT Vaccines Market Facts & Figures by Country
- 5.7.1 South America DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America DPT Vaccines Sales by Country (2021-2032)
- 5.7.3 South America DPT Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa DPT Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global DPT Vaccines Sales by Type (2021-2032)
- 6.1.1 Global DPT Vaccines Sales by Type (2021-2032) & (M Doses)
- 6.1.2 Global DPT Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global DPT Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global DPT Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global DPT Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global DPT Vaccines Price by Type (2021-2032)
7 Segment by Age
- 7.1 Global DPT Vaccines Sales by Age (2021-2032)
- 7.1.1 Global DPT Vaccines Sales by Age (2021-2032) & (M Doses)
- 7.1.2 Global DPT Vaccines Sales Market Share by Age (2021-2032)
- 7.2 Global DPT Vaccines Revenue by Age (2021-2032)
- 7.2.1 Global DPT Vaccines Sales by Age (2021-2032) & (US$ Million)
- 7.2.2 Global DPT Vaccines Revenue Market Share by Age (2021-2032)
- 7.3 Global DPT Vaccines Price by Age (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 DPT Vaccines Value Chain Analysis
- 8.1.1 DPT Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 DPT Vaccines Production Mode & Process
- 8.2 DPT Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 DPT Vaccines Distributors
- 8.2.3 DPT Vaccines Customers
9 Global DPT Vaccines Analyzing Market Dynamics
- 9.1 DPT Vaccines Industry Trends
- 9.2 DPT Vaccines Industry Drivers
- 9.3 DPT Vaccines Industry Opportunities and Challenges
- 9.4 DPT Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst